Exelon憶思能

Exelon Adverse Reactions

rivastigmine

Manufacturer:

Novartis

Distributor:

Zuellig
/
Four Star
Full Prescribing Info
Adverse Reactions
The most commonly reported adverse drug reactions are gastrointestinal including nausea (38%) and vomiting (23%), especially during titration. Female patients in clinical studies were found to be more susceptible to gastrointestinal adverse drug reactions and weight loss.
Adverse reactions in Table 2 and 3 are ranked under headings of frequency, the most frequent first, using the following convention: Very common (≥1/10); common (≥1/100, <1/10); uncommon (≥1/1,000, <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10,000), including isolated reports. (See Tables 2 and 3.)

Click on icon to see table/diagram/image


Click on icon to see table/diagram/image

Additional adverse reactions observed during a 76-week prospective, open-label study in patients with dementia associated with Parkinson's disease treated with Exelon capsules: hypertension, hypotension (common).
The following additional adverse drug reactions have been reported in a clinical study in patients with dementia associated with Parkinson's disease treated with Exelon Patch: agitation, depression (common).
Additional adverse drug reactions which have been reported with Exelon Patch: Common: urinary incontinence.
Uncommon: cerebrovascular accident, delirium, psychomotor hyperactivity.
Rarely reported: erythema, urticaria, blister, dermatitis allergic.
Information from clinical trials in patients with dementia associated with Parkinson's disease: Table 4 lists the number and percentage of patients from the specific 24-week clinical study conducted with Exelon in patients with dementia associated with Parkinson's disease with pre-defined events that may reflect worsening of Parkinson's disease. (See Table 4.)

Click on icon to see table/diagram/image
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in